Results for tag: "Bronchiectasis Drug"

Bronchiectasis is a chronic lung disease that causes irreversible damage to the airways. It is characterized by abnormal and irreversible widening of the bronchi, leading to recurrent infections and difficulty breathing. Treatment for bronchiectasis includes antibiotics, bronchodilators, and mucolytics. Inhaled corticosteroids may also be used to reduce inflammation. The bronchiectasis drug market is a subset of the larger respiratory drug market. It is composed of drugs used to treat bronchiectasis, including antibiotics, bronchodilators, mucolytics, and inhaled corticosteroids. These drugs are used to reduce inflammation, reduce mucus production, and improve airway clearance. Some companies in the bronchiectasis drug market include GlaxoSmithKline, AstraZeneca, Merck, Novartis, and Boehringer Ingelheim. Show Less Read more